The Heartland Unit for Neuroscience Trials collaborates with local and national scientists to bring leading-edge clinical trials to Kansas City.
History: In 2011, The University of Kansas Medical Center was selected by the National Institute of Neurological Disorders and Stroke (NINDS) as one of 25 U.S. sites designated to participate in the Network of Excellence in Neuroscience Clinical Trials (NeuroNEXT). See story
Goals: This network conducts exploratory (Phase II) studies of treatments for neurological diseases in adults and children through partnerships with academia, private foundations and industry. NeuroNEXT is designed to expand NINDS's capability to test the most promising new therapies; increase the efficiency of clinical trials before embarking on larger studies; and respond quickly as new opportunities arise to test promising treatments for people with neurological disorders.
Our mission: In response to the NeuroNEXT initiative (RFA-NS-11-008), KU formed the Heartland Unit for Neuroscience Trials (HUNT), which is headquartered at KU's Clinical Research Center. HUNT provides infrastructure, centralized resources, access to patients, and coordination of our region's neuroscience investigators, thereby increasing their responsiveness and efficiency in conducting those NINDS trials.